These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Fisniku LK; Brex PA; Altmann DR; Miszkiel KA; Benton CE; Lanyon R; Thompson AJ; Miller DH Brain; 2008 Mar; 131(Pt 3):808-17. PubMed ID: 18234696 [TBL] [Abstract][Full Text] [Related]
5. A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta. Galassi S; Prosperini L; Logoteta A; Hirsch MN; Fanelli F; De Giglio L; Pozzilli C Mult Scler Relat Disord; 2016 Jul; 8():99-106. PubMed ID: 27456883 [TBL] [Abstract][Full Text] [Related]
6. Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis. Usta NC; Boz C; Terzi M Clin Neurol Neurosurg; 2023 Jan; 224():107528. PubMed ID: 36446265 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Kappos L; Moeri D; Radue EW; Schoetzau A; Schweikert K; Barkhof F; Miller D; Guttmann CR; Weiner HL; Gasperini C; Filippi M Lancet; 1999 Mar; 353(9157):964-9. PubMed ID: 10459905 [TBL] [Abstract][Full Text] [Related]
8. Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis. Uher T; Vaneckova M; Sobisek L; Tyblova M; Seidl Z; Krasensky J; Ramasamy D; Zivadinov R; Havrdova E; Kalincik T; Horakova D Mult Scler; 2017 Jan; 23(1):51-61. PubMed ID: 27053635 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G; J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489 [TBL] [Abstract][Full Text] [Related]
12. Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis. Pravatà E; Valsasina P; Gobbi C; Zecca C; Riccitelli GC; Filippi M; Rocca MA Mult Scler; 2020 Oct; 26(11):1402-1409. PubMed ID: 31347448 [TBL] [Abstract][Full Text] [Related]
13. Information processing speed as a prognostic marker of physical impairment and progression in patients with multiple sclerosis. Hechenberger S; Helmlinger B; Ropele S; Pirpamer L; Bachmaier G; Damulina A; Pichler A; Khalil M; Enzinger C; Pinter D Mult Scler Relat Disord; 2022 Jan; 57():103353. PubMed ID: 35158430 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study. Traboulsee A; Li DKB; Cascione M; Fang J; Dangond F; Miller A BMC Neurol; 2018 May; 18(1):68. PubMed ID: 29751787 [TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
16. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study. Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979 [TBL] [Abstract][Full Text] [Related]
18. Spinal cord volume loss: A marker of disease progression in multiple sclerosis. Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K Neurology; 2018 Jul; 91(4):e349-e358. PubMed ID: 29950437 [TBL] [Abstract][Full Text] [Related]
19. Comparison of brainstem reflex recordings and evoked potentials with clinical and MRI data to assess brainstem dysfunction in multiple sclerosis: a short-term follow-up. Magnano I; Pes GM; Cabboi MP; Pilurzi G; Ginatempo F; Achene A; Salis A; Conti M; Deriu F Neurol Sci; 2016 Sep; 37(9):1457-65. PubMed ID: 27177651 [TBL] [Abstract][Full Text] [Related]
20. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]